Skip to content

Salt ALTernatives Study (SALTS): A smartphone app and dietary alternative salt to lower blood pressure for adults with high blood pressure

Salt ALTernatives Study (SALTS): A randomised controlled trial to determine the effects of a 12-week dietary salt reduction intervention (SaltSwitch app + dietary alternative salt) on systolic blood pressure in adults with high blood pressure

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000352101
Acronym
SALTS (Salt ALTernatives Study)
Enrollment
168
Registered
2019-03-06
Start date
2019-05-30
Completion date
2020-12-18
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

High blood pressure (BP) alone accounts for 8.3% of health loss in NZ and is a major risk factor for cardiovascular disease, New Zealands leading cause of early death. Adherence to a low salt diet is critical to reduce BP, yet New Zealand adults currently consume ~40% more salt than recommendations, and identifying foods low in salt and changing habits around discretionary salt intake can be challenging. New Zealand does not currently have a national sodium reduction strategy and the food industry has been slow to remove excess salt from packaged foods. Therefore, more effective, scalable dietary salt reduction interventions are urgently needed. The SALTS trial will determine the effects of a dietary salt reduction intervention (SaltSwitch smartphone application (app) + dietary alternative salt) on systolic BP in adults with high BP.

Interventions

The intervention is designed to lower blood pressure and includies two components: (1) a smartphone application (app) called SaltSwitch, and (2) a dietary alternative salt. The SaltSwitch app helps users to select lower salt packaged foods by enabling them to scan the barcode of a packaged food and receive an immediate, interpretive traffic light nutrition label on-screen plus suggestions for lower salt alternatives. Users can also directly compare the salt content and healthiness of two or m

The intervention is designed to lower blood pressure and includies two components: (1) a smartphone application (app) called SaltSwitch, and (2) a dietary alternative salt. The SaltSwitch app helps users to select lower salt packaged foods by enabling them to scan the barcode of a packaged food and receive an immediate, interpretive traffic light nutrition label on-screen plus suggestions for lower salt alternatives. Users can also directly compare the salt content and healthiness of two or more food products. The dietary alternative salt is a blend of potassium salt and sea salt which provides a 75% reduction in sodium compared to regular table salt. The dietary alternative salt comprises 74.5% potassium chloride and 24.5% sodium chloride and ~1% silicon dioxide (anticaking agent). Intervention participants will receive weekly notifications to their smart phone to remind them to use the SaltSwitch app and dietary alternative salt. Participants will be encouraged to use the dietary alternative salt in place of regular table salt in cooking and at the table, but not to use more or less salt than usual. Delivery of the intervention will be entirely remote with the smartphone app downloaded to participants phones during the randomisation phone call, and the dietary alternative salt being sent by courier to the participant shortly thereafter. Google analytics will be used to monitor use of the SaltSwitch app by individual participants who have WiFii, and the amount of dietary alternative salt left over at the end of the 12-week intervention period will be self-reported in household measures (tsp). Use and acceptibility of the SaltSwitch app and dietary alternative salt will also be self-reported in the follow-up questionnaire.

Sponsors

National Institute for Health Innovation
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aged 18 years or older Own a smartphone (iPhone or Android) Have a systolic blood pressure of greater than or equal to 140mmHg and/or diastolic blood pressure of greater than or equal to 85mmHg at screening Are willing to contribute to grocery shopping during the study period Are able to read and understand English

Exclusion criteria

Currently use a dietary alternative salt Currently use the FoodSwitch smartphone app Have a contraindication to changing dietary sodium intake e.g. severe kidney disease or use of a potassium sparing diuretic Are taking medication that may lead to hyponatraemia or acute build-up of body water such as furosemide, regular NSAID use, or regular prednisone use Have had a stroke or cardiovascular event (hospitalisation for heart attack, coronary artery revascularisation (CABG or stenting), stroke or heart failure) in the previous 6 months Have diagnosed heart failure Do not provide at least six home-based blood pressure measures during week two of baseline (week -2) Do not return a spot (casual) urine sample at week -1 of baseline Are planning on going away for two or more weeks over the next 14 weeks Are unable to provide informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 10, 2026